Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794950
Max Phase: Preclinical
Molecular Formula: C52H78N6O22S2
Molecular Weight: 1203.35
Molecule Type: Unknown
Associated Items:
ID: ALA4794950
Max Phase: Preclinical
Molecular Formula: C52H78N6O22S2
Molecular Weight: 1203.35
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCC(=O)N(C)[C@H](CO)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)Cc2ccc(OS(=O)(=O)O)c(c2)-c2cc1cc(OS(=O)(=O)O)c2O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C52H78N6O22S2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-40(60)57(5)37(28-59)49(67)54-29(2)47(65)53-27-41(61)58(6)42-33-25-35(46(39(26-33)80-82(74,75)76)78-52-45(64)44(63)43(62)31(4)77-52)34-23-32(21-22-38(34)79-81(71,72)73)24-36(51(69)70)56-48(66)30(3)55-50(42)68/h21-23,25-26,29-31,36-37,42-45,52,59,62-64H,7-20,24,27-28H2,1-6H3,(H,53,65)(H,54,67)(H,55,68)(H,56,66)(H,69,70)(H,71,72,73)(H,74,75,76)/t29-,30+,31+,36+,37-,42+,43+,44-,45-,52+/m1/s1
Standard InChI Key: DHOGTCWRDDGRRR-NTENQVQJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1203.35 | Molecular Weight (Monoisotopic): 1202.4611 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Tan YX,Peters DS,Walsh SI,Holcomb M,Santos-Martins D,Forli S,Romesberg FE. (2020) Initial Analysis of the Arylomycin D Antibiotics., 83 (7): [PMID:32614583] [10.1021/acs.jnatprod.9b01174] |
Source(1):